Pharmacotherapy for major depression in children and adolescents

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Major depression is a serious illness in children which adversely effects their social, academic, and emotional development. It is essential to identify safe and effective medication for the treatment of this disorder in youths. Only some selective serotonin reuptake inhibitors (citalopram, fluoxetine, sertraline) have demonstrated superiority to placebo on primary outcome measures in acute controlled treatment trials. This article will review acute efficacy studies as well as long-term studies of antidepressants for the treatment of childhood depression. Treatment recommendations are discussed and the issue of suicidality and antidepressants are addressed.

Original languageEnglish (US)
Pages (from-to)819-826
Number of pages8
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume29
Issue number5
DOIs
StatePublished - Jun 2005
Externally publishedYes

Fingerprint

Drug Therapy
Antidepressive Agents
Sertraline
Citalopram
Fluoxetine
Serotonin Uptake Inhibitors
Therapeutics
Placebos
Outcome Assessment (Health Care)

Keywords

  • Antidepressants
  • Bupropion
  • Citalopram
  • Escitalopram
  • Fluoxetine
  • Major depression
  • Mirtazapine
  • Monoamine oxidase inhibitors
  • Nefazodone
  • Paroxetine
  • Selective serotonin reuptake inhibitors
  • Sertraline
  • Suicidality
  • Venlafaxine

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Pharmacotherapy for major depression in children and adolescents. / Wagner, Karen.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 29, No. 5, 06.2005, p. 819-826.

Research output: Contribution to journalArticle

@article{eead7bb75f5d4b668e3afc715baea197,
title = "Pharmacotherapy for major depression in children and adolescents",
abstract = "Major depression is a serious illness in children which adversely effects their social, academic, and emotional development. It is essential to identify safe and effective medication for the treatment of this disorder in youths. Only some selective serotonin reuptake inhibitors (citalopram, fluoxetine, sertraline) have demonstrated superiority to placebo on primary outcome measures in acute controlled treatment trials. This article will review acute efficacy studies as well as long-term studies of antidepressants for the treatment of childhood depression. Treatment recommendations are discussed and the issue of suicidality and antidepressants are addressed.",
keywords = "Antidepressants, Bupropion, Citalopram, Escitalopram, Fluoxetine, Major depression, Mirtazapine, Monoamine oxidase inhibitors, Nefazodone, Paroxetine, Selective serotonin reuptake inhibitors, Sertraline, Suicidality, Venlafaxine",
author = "Karen Wagner",
year = "2005",
month = "6",
doi = "10.1016/j.pnpbp.2005.03.005",
language = "English (US)",
volume = "29",
pages = "819--826",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Pharmacotherapy for major depression in children and adolescents

AU - Wagner, Karen

PY - 2005/6

Y1 - 2005/6

N2 - Major depression is a serious illness in children which adversely effects their social, academic, and emotional development. It is essential to identify safe and effective medication for the treatment of this disorder in youths. Only some selective serotonin reuptake inhibitors (citalopram, fluoxetine, sertraline) have demonstrated superiority to placebo on primary outcome measures in acute controlled treatment trials. This article will review acute efficacy studies as well as long-term studies of antidepressants for the treatment of childhood depression. Treatment recommendations are discussed and the issue of suicidality and antidepressants are addressed.

AB - Major depression is a serious illness in children which adversely effects their social, academic, and emotional development. It is essential to identify safe and effective medication for the treatment of this disorder in youths. Only some selective serotonin reuptake inhibitors (citalopram, fluoxetine, sertraline) have demonstrated superiority to placebo on primary outcome measures in acute controlled treatment trials. This article will review acute efficacy studies as well as long-term studies of antidepressants for the treatment of childhood depression. Treatment recommendations are discussed and the issue of suicidality and antidepressants are addressed.

KW - Antidepressants

KW - Bupropion

KW - Citalopram

KW - Escitalopram

KW - Fluoxetine

KW - Major depression

KW - Mirtazapine

KW - Monoamine oxidase inhibitors

KW - Nefazodone

KW - Paroxetine

KW - Selective serotonin reuptake inhibitors

KW - Sertraline

KW - Suicidality

KW - Venlafaxine

UR - http://www.scopus.com/inward/record.url?scp=21244443141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244443141&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2005.03.005

DO - 10.1016/j.pnpbp.2005.03.005

M3 - Article

VL - 29

SP - 819

EP - 826

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 5

ER -